News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cardax Pharmaceuticals Inc. Release: Recent Studies Further Demonstrate Astaxanthin’s Potential As A Safe And Effective Anti-Inflammatory


5/19/2014 10:00:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HONOLULU--(BUSINESS WIRE)--Recent studies continue to support astaxanthin’s broad potential in chronic inflammatory disease, adding to more than 1,000 peer-reviewed papers published on astaxanthin. Selected publications from January 2013 to April 2014 include (i) a thorough review of astaxanthin and its applications, (ii) human studies in cognitive decline, cardiovascular oxidation, and ocular dysfunction, and (iii) animal and mechanistic studies addressing brain health and cognitive decline related pathology, osteoarthritis and joint health, metabolism, cardiovascular health, and related diseases, eye and retinal health, skin protection and health, lung function and health, and kidney function and health (see highlights below).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES